Articles

Quick View: FDA Approves BMS's Breyanzi, Making It The First CAR-T Cell Therapy Indicated For Two Types Of Leukaemia

Pharmaceuticals / United States / Mon 18 Mar, 2024

The Latest: On March 14 2024, Bristol Myers Squibb (BMS) secured an accelerated FDA approval for Breyanzi (lisocabtagene maraleucel) as the first and only CAR T-cell therapy for adults with relapsed or refractory chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL). The approval is based on positive results from a Phase I/II

Read More

Bangladesh To Be Increasingly Reliant On LNG Imports

Oil & Gas / Bangladesh / Fri 15 Mar, 2024

Key View

  • We anticipate that Bangladesh’s natural gas supply woes will worsen due to insufficient investment in upstream exploration activities.
  • The industrial sector is expected to emerge as the largest source of natural gas demand growth in the short and medium terms.
  • Supply-demand imbalances are set to grow further, keeping Bangladesh
Read More
Download Indicator Summary
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Clearbit Form
 

Thank you. Your download link will be emailed to you shortly.